SANUWAVE Health, Inc. (SNWV) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US80303D3052
SANUWAVE Health, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 44.05 m USD |
| Gross profit | 33.97 m USD |
| Operating income | 4.95 m USD |
| EBIT | 11.90 m USD |
| Net income | 11.81 m USD |
| Diluted EPS – continuing operations | 0.41 USD |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
More stocks
- Cue Biopharma, Inc. (CUE)
- Beeline Holdings, Inc. (BLNE)
- Security Midwest Bancorp, Inc. (SBMW)
- Starco Brands, Inc. (STCB)
- Beam Global (BEEM)
- Cosmos Health Inc. (COSM)
- Seres Therapeutics, Inc. (MCRB)
- Vivid Seats Inc. (SEAT)
- Estrella Immunopharma, Inc. (ESLA)
- SBI Investment KOREA Co. Ltd (019550.KQ)
- PACIFIC HEALTH CARE ORGANIZATION INC (PFHO)
- ARTS WAY MANUFACTURING CO INC (ARTW)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.